Veterinary Medicines

Virbagen felis RC Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension für Katzen

Authorised
  • Feline calicivirus, strain F9, Live
  • Felid herpesvirus 1, strain F2, Live
Download as PDF

Product identification

Medicine name:
Virbagen felis RC Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension für Katzen
Active substance:
  • Feline calicivirus, strain F9, Live
  • Felid herpesvirus 1, strain F2, Live
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline calicivirus, strain F9, Live
    39810.00
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Felid herpesvirus 1, strain F2, Live
    100000.00
    50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AD03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac Tierarzneimittel GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.03598.01.1
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 8/01/2026
Download

2604190-parde-20080901.pdf

German (PDF)
Published on: 8/01/2026
Download

2604190-parde-20080901.pdf

German (PDF)
Published on: 9/09/2024
Download